The Aporia
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro. (2026, September 29). Toronto Star. https://www.thestar.com/globenewswire/quantum-si-presents-interim-proteus-data-at-world-hupo-2026-demonstrating-a-significant-step-change/article_e050a7c2-57cf-5df4-ab29-fac70d28d615.html
“Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro.” Toronto Star, 29 Sept. 2026, https://www.thestar.com/globenewswire/quantum-si-presents-interim-proteus-data-at-world-hupo-2026-demonstrating-a-significant-step-change/article_e050a7c2-57cf-5df4-ab29-fac70d28d615.html.
“Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro.” Toronto Star, September 29, 2026. https://www.thestar.com/globenewswire/quantum-si-presents-interim-proteus-data-at-world-hupo-2026-demonstrating-a-significant-step-change/article_e050a7c2-57cf-5df4-ab29-fac70d28d615.html.
Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.
Quantum-Si Incorporated, a proteomics company based in BRANFORD, Connecticut, announced significant interim results for its Proteus™ platform at the 2026 World HUPO Congress in Singapore on September 29, 2026. Using an experimental kit that detects 18 amino acids, Proteus outperformed Quantum-Si's commercially available Platinum® Pro instrument across all key performance measures, including sequencing scale, accuracy, peptide identification, and protein sequence coverage. These findings were presented by Jeff Hawkins, President and CEO of Quantum-Si, during a seminar at the conference. Notably, while the Proteus platform is still under development and not fully optimized, it already demonstrates superior capabilities compared to Platinum Pro.